科懋生物科技股份有限公司
科懋生物科技股份有限公司（Excelsior Biopharma Inc.）在台灣及中國開發銷售醫藥產品。提供學名藥、罕見疾病藥物（孤兒藥）、解毒劑、快篩試劑及特殊醫學營養品。涉及原料藥進出口與醫藥技術轉讓。公司成立於 1986 年，總部位於台灣台北。
今日下跌 1.47%，股價跌破短期均線。該股 RSI(6) 為 21.5，處於偏低區間，短線賣壓漸緩。股價跌破5日、20日、60日、120日均線。短中期均線呈空頭排列，趨勢偏空。KD 指標中性（K=32.4）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 09-21 | +3 | 0 | 0 | +3 |
| 09-18 | +3 | 0 | 0 | +3 |
| 08-21 | 0 | 0 | 0 | 0 |
| 08-18 | -1 | 0 | 0 | -1 |
| 08-14 | +1 | 0 | 0 | +1 |
| 08-12 | -1 | 0 | 0 | -1 |
| 08-10 | +1 | 0 | 0 | +1 |
| 08-05 | +1 | 0 | 0 | +1 |
| 07-29 | -7 | 0 | 0 | -7 |
| 07-28 | -2 | 0 | 0 | -2 |
| 07-22 | -1 | 0 | 0 | -1 |
| 07-17 | +2 | 0 | 0 | +2 |
| 07-14 | 0 | 0 | 0 | 0 |
| 07-09 | -2 | 0 | 0 | -2 |
| 07-08 | -1 | 0 | 0 | -1 |
| 07-07 | 0 | 0 | 0 | 0 |
| 07-06 | +1 | 0 | 0 | +1 |
| 07-03 | +2 | 0 | 0 | +2 |
| 07-01 | -2 | 0 | 0 | -2 |
| 06-30 | -2 | 0 | 0 | -2 |
| 06-26 | -1 | 0 | 0 | -1 |
| 06-25 | -2 | 0 | 0 | -2 |
| 06-24 | 0 | 0 | 0 | 0 |
| 06-23 | +2 | 0 | 0 | +2 |
| 06-17 | -1 | 0 | 0 | -1 |
| 06-16 | -3 | 0 | 0 | -3 |
| 06-12 | -1 | 0 | 0 | -1 |
| 06-10 | -1 | 0 | 0 | -1 |
| 06-09 | +3 | 0 | 0 | +3 |
| 06-08 | +3 | 0 | 0 | +3 |
| 06-05 | 0 | 0 | 0 | 0 |
| 06-04 | +2 | 0 | 0 | +2 |
| 06-03 | 0 | 0 | 0 | 0 |
| 06-02 | -5 | 0 | 0 | -5 |
| 06-01 | +2 | 0 | 0 | +2 |
| 05-29 | -3 | 0 | 0 | -3 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/04 | 8533 萬 | +29.3% | +28.9% |
| 2026/03 | 6600 萬 | +16.9% | -16.2% |
| 2026/02 | 5644 萬 | -41.0% | -6.6% |
| 2026/01 | 9561 萬 | -23.9% | +35.1% |
| 2025/12 | 1.26 億 | +52.9% | +34.2% |
| 2025/11 | 8214 萬 | +14.9% | +12.3% |
| 2025/10 | 7149 萬 | +0.4% | -3.4% |
| 2025/09 | 7118 萬 | +3.9% | -4.6% |
| 2025/08 | 6848 萬 | +1.5% | -4.7% |
| 2025/07 | 6748 萬 | +7.0% | -6.0% |
| 2025/06 | 6305 萬 | -13.3% | -7.4% |
| 2025/05 | 7273 萬 | - | -5.0% |